Literature DB >> 24600562

Detectability and reproducibility of plasma levels of chemokines and soluble receptors.

Ilir Agalliu1, Xiaonan Xue1, Mary Cushman2, Elaine Cornell3, Ann W Hsing4, Robert C Kaplan1, Kathryn Anastos5, Swapnil Rajpathak6, Gloria Y F Ho1.   

Abstract

BACKGROUND: Multiplex assays are available to measure an array of circulating chemokines, soluble cytokine receptors and growth factors. However, there is limited information regarding whether these analytes are suitable for large-scale epidemiological studies to assess their relationships with chronic diseases, including cancer.
METHODS: We examined detectability, assay repeatability, and 3-year within-subject reproducibility of plasma levels of 25 chemokines and 11 soluble receptors of cytokines and growth factors selected from the Human Millipore Panels. Plasma samples were obtained from 36 men (average age 62 years) and 17 women (average age 32 years) who participated in two epidemiological studies. Inter-assay and within-subject reproducibility were assessed by intraclass correlation coefficients (ICC).
RESULTS: All analytes, except lymphotactin (47% detectability), were detectable in >90% of plasma samples. Inter-assay reproducibility for all analytes in 36 men tested three times on separate days were good to excellent (ICCs: 0.71-1.00). Within-subject reproducibility in 17 women sampled three times in three years were excellent (ICC ≥ 0.75) for five chemokines (eotaxin, fractalkine, 6Ckine, eotaxin 3, and SDF-1α+β) and three soluble receptors (sIL-1R2, sIL-4R and sVEGFR2); ICCs were fair to good (0.4 ≤ ICC < 0.75) for 15 chemokines and eight soluble receptors. However, five chemokines (GRO, IP-10, MIP-1β, BCA-1, and MIP-3α) had ICC < 0.4, suggesting biological variability.
CONCLUSION: Multiplex assays for plasma levels of selected chemokines and soluble receptors showed good to excellent assay detectability and repeatability. Most analytes also had good 3-year within-subject reproducibility, indicating that a single measurement of these analytes may be used to assess biomarker-disease associations.

Entities:  

Keywords:  Biomarker; Chemokines; Limit of detection; Soluble receptors; Within-subject variability

Year:  2013        PMID: 24600562      PMCID: PMC3908322          DOI: 10.1016/j.rinim.2013.07.001

Source DB:  PubMed          Journal:  Results Immunol        ISSN: 2211-2839


  36 in total

Review 1.  The inflammatory tumor microenvironment and its impact on cancer development.

Authors:  Karin E de Visser; Lisa M Coussens
Journal:  Contrib Microbiol       Date:  2006

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 4.  Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.

Authors:  A Ben-Baruch
Journal:  Semin Cancer Biol       Date:  2005-08-31       Impact factor: 15.707

5.  Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study.

Authors:  Anil K Chaturvedi; Troy J Kemp; Ruth M Pfeiffer; Angelique Biancotto; Marcus Williams; Stella Munuo; Mark P Purdue; Ann W Hsing; Ligia Pinto; J Philip McCoy; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-29       Impact factor: 4.254

Review 6.  Cytokine disbalance in common human cancers.

Authors:  Zoran Culig
Journal:  Biochim Biophys Acta       Date:  2010-12-15

7.  Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women.

Authors:  Gloria Y F Ho; Xiao-Nan Xue; Robert D Burk; Robert C Kaplan; Elaine Cornell; Mary Cushman
Journal:  Cytokine       Date:  2005-04-07       Impact factor: 3.861

8.  Temporal reliability of cytokines and growth factors in EDTA plasma.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin
Journal:  BMC Res Notes       Date:  2010-11-13

9.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

Authors:  Wilco de Jager; Katarzyna Bourcier; Ger T Rijkers; Berent J Prakken; Vicki Seyfert-Margolis
Journal:  BMC Immunol       Date:  2009-09-28       Impact factor: 3.615

10.  A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers.

Authors:  C McIlhenny; W D George; J C Doughty
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

View more
  12 in total

1.  Fractalkine (C-X3-C motif chemokine ligand 1) as a potential biomarker for depression and anxiety in colorectal cancer patients.

Authors:  Diego Oliveira Miranda; Elen Anatriello; Lucas Ribeiro Azevedo; Jessica Cristina Santos; Jessica Fernanda Correa Cordeiro; Fernanda Maris Peria; Milena Flória-Santos; Gabriela Pereira-Da-Silva
Journal:  Biomed Rep       Date:  2017-07-04

2.  Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.

Authors:  Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream
Journal:  Cytokine       Date:  2016-12-09       Impact factor: 3.861

3.  Circulating soluble cytokine receptors and colorectal cancer risk.

Authors:  Gloria Y F Ho; Tao Wang; Siqun L Zheng; Lesley Tinker; Jianfeng Xu; Thomas E Rohan; Sylvia Wassertheil-Smoller; Xiaonan Xue; Leonard H Augenlicht; Ulrike Peters; Amanda I Phipps; Howard D Strickler; Marc J Gunter; Mary Cushman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-05       Impact factor: 4.254

4.  Elevated Fractalkine (CX3CL1) Levels in the Trigeminal Ganglion Mechanically Sensitize Temporalis Muscle Nociceptors.

Authors:  Brian E Cairns; Melissa O'Brien; Xu-Dong Dong; Parisa Gazerani
Journal:  Mol Neurobiol       Date:  2016-05-21       Impact factor: 5.590

5.  An investigation of vago-regulatory and health-behavior accounts for increased inflammation in posttraumatic stress disorder.

Authors:  Paul A Dennis; J Brice Weinberg; Patrick S Calhoun; Lana L Watkins; Andrew Sherwood; Michelle F Dennis; Jean C Beckham
Journal:  J Psychosom Res       Date:  2016-02-26       Impact factor: 3.006

6.  Novel pleiotropic effects of bioactive phospholipids in human lung cancer metastasis.

Authors:  Gabriela Schneider; Zachariah Payne Sellers; Kamila Bujko; Sham S Kakar; Magda Kucia; Mariusz Z Ratajczak
Journal:  Oncotarget       Date:  2017-04-27

7.  Regulation of CCR7-dependent cell migration through CCR7 homodimer formation.

Authors:  Daichi Kobayashi; Masataka Endo; Hirotaka Ochi; Hironobu Hojo; Masayuki Miyasaka; Haruko Hayasaka
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

8.  Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases.

Authors:  Martin Trapecar; Emile Wogram; Devon Svoboda; Catherine Communal; Attya Omer; Tenzin Lungjangwa; Pierre Sphabmixay; Jason Velazquez; Kirsten Schneider; Charles W Wright; Samuel Mildrum; Austin Hendricks; Stuart Levine; Julien Muffat; Meelim Jasmine Lee; Douglas A Lauffenburger; David Trumper; Rudolf Jaenisch; Linda G Griffith
Journal:  Sci Adv       Date:  2021-01-29       Impact factor: 14.136

9.  The "Aging Factor" Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor's Age.

Authors:  Julia Hoefer; Markus Luger; Christian Dal-Pont; Zoran Culig; Harald Schennach; Stefan Jochberger
Journal:  Front Aging Neurosci       Date:  2017-12-01       Impact factor: 5.750

10.  Mosquito saliva alone has profound effects on the human immune system.

Authors:  Megan B Vogt; Anismrita Lahon; Ravi P Arya; Alexander R Kneubehl; Jennifer L Spencer Clinton; Silke Paust; Rebecca Rico-Hesse
Journal:  PLoS Negl Trop Dis       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.